Pharmarise Holdings Corporation (2796) — research page
JP · jp-cm-kg/TSE-STANDARD/2796 · as of 2026-11-06
Identity and listing
The issuer is Pharmarise Holdings Corporation, listed on the Standard Market of the Japanese exchange under ticker 2796. The ISIN is not on the record and the LEI is not on the record. Its security type is Corporate, its sector is 6100 Retail Trade, and its jurisdiction is Japan (EDINET domestic filer). Its segment is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Pharmarise Holdings Corporation | source · 2026-11-06 |
| exchange | Standard Market | source · 2026-11-06 |
| ticker | 2796 | source · 2026-11-06 |
| ISIN | not on the record | |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | 6100 Retail Trade | source · 2026-11-06 |
| jurisdiction | Japan (EDINET domestic filer) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 11 filings in the twelve months to 2026-11-06, across 8 filing days. Of these, 5 are ad hoc, 4 are regulatory filings and 2 are results. The median gap between filing days is 13 days. The latest filing is dated 2026-08-31, is of type ad hoc, and falls 67 days before the record date. On the Standard Market the median filings count is 7, the median cadence gap is 67.5 days and the median latency is 107 days across 1559 issuers. In the 6100 Retail Trade sector the median filings count is 7.0, the median cadence gap is 49 days and the median latency is 72.5 days across 342 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 11 | 13 | 67 |
| exchange median: Standard Market (1559 issuers) | 7 | 67.5 | 107 |
| sector median: 6100 Retail Trade (342 issuers) | 7 | 49 | 72.5 |
| date | type | category | filing |
|---|---|---|---|
| 2026-08-31 | ad_hoc | 臨時報告書 (extraordinary report) | 臨時報告書 |
| 2026-08-20 | regulatory_filing | 235 | 内部統制報告書－第40期(2025/06/01－2026/05/31) |
| 2026-08-20 | regulatory_filing | 135 | 確認書 |
| 2026-08-20 | results | 有価証券報告書 (annual securities report) | 有価証券報告書－第40期(2025/06/01－2026/05/31) |
| 2026-08-18 | ad_hoc | 臨時報告書 (extraordinary report) | 臨時報告書 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is 太陽有限責任監査法人. Its location is not on the record. Auditor changes are not on the record, because the register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag is listed, not halted.
Orderability
For Qualified Institutional Investors the outcome is not determinable. The rule states a product scope and the subject's record carries no instrument class to place within it. The signal code is null. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Qualified Institutional Investors | not determinable: the rule states a product scope and the subject's record carries no instrument class to place within it |
rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages.
Open research
Four openly published research notes are on the record, all by Sessa Investment Research: 2024-01-25, 2024-09-10, 2025-02-25 and 2025-09-02.
| date | publisher | note | kind |
|---|---|---|---|
| 2025-09-02 | Sessa Investment Research | Pharmarise HDS Q4 FY2025/5 Follow-up | issuer-sponsored |
| 2025-02-25 | Sessa Investment Research | Phamrise HDS Full report 2025 | issuer-sponsored |
| 2024-09-10 | Sessa Investment Research | Pharmarise HDS 4Q FY2024/5 Follow-up | issuer-sponsored |
| 2024-01-25 | Sessa Investment Research | Pharmarise HDS｜2796 | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No years are sealed for the issuer, the market earliest sealed date is not on the record, and the live record began is not on the record.
Sources
11 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- 10.2
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- 10.3
- https://mcp.jp-cm-kg.ai/events/TSE-STANDARD/2796 (the disclosure lines)
- 10.4
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- 10.5
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YXWI (the auditor)
- 10.6
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.pharmarise.com/en/ir/data/pdf/PharmariseHD_EN_20250902.pdf (open research)
- 10.8
- https://www.pharmarise.com/en/ir/data/pdf/PharmariseHD_EN_20250225.pdf (open research)
- 10.9
- https://www.pharmarise.com/en/ir/data/pdf/PharmariseHD_EN_20240910.pdf (open research)
- 10.10
- https://www.pharmarise.com/en/ir/data/pdf/PharmariseHD_EN_20240125.pdf (open research)
- 10.11
- https://mcp.jp-cm-kg.ai/record/TSE-STANDARD/2796 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"2796","exchange":"Standard Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:20fcd3f62d98d876.